Question to the Department for International Trade:

To ask the Secretary of State for International Trade, what assessment she has made of the UK's ability to export plasma products after the transition period ends on 31 December.

The Department for International Trade (DIT) is working to open markets for UK exporters all over the world and do whatever it takes to ensure they have what they need to succeed. This includes replicating EU trade agreements to provide continuity, as well as negotiating additional arrangements to unlock new opportunities for UK businesses.

The Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be the competent authority for regulating the import and export of blood-based products. The same standards will be applied, and regulations will be in place to ensure that the safety and quality requirements for the import and export of blood-based products will continue to be met.